Supplements / ADHD
Saffron and ADHD: an early signal worth keeping in perspective.
A handful of small trials compared saffron with methylphenidate. That is interesting research—and nowhere near enough to swap treatments.
Source-linked information, not individual medical advice. A qualified clinician should review this health content before public launch. Do not start, stop or change a supplement or treatment based on this page.
THE USEFUL DISTINCTION
A 2024 systematic review found four clinical trials with 118 participants in total; saffron performed comparably to methylphenidate in two small head-to-head trials and appeared to add benefit as an add-on in two others.[1]
Why it is still early
Four trials and 118 people is a very small evidence base. The studies were short and not widely replicated across different countries or research teams. Comparable-looking results in a small trial can still hide real differences.
Saffron used in research is a standardized extract at measured doses, not culinary saffron or an unregulated capsule. High doses of saffron can be harmful, and quality varies between products.
Who does this apply to?
Children, adolescents and adults in small clinical trials, mostly in one region.
What remains uncertain?
Long-term safety, the right dose, product quality, and whether results hold in larger, independent trials.
Questions for your clinician
These are conversation prompts, not a suggested treatment plan.
- Is there any reason saffron would be inappropriate for me or my child?
- How would this fit with—not replace—our current plan?
- How would we monitor whether it is working or causing side effects?
Sources & context
Sources checked October 3, 2026. These links support this brief; they do not imply an endorsement of NeuroCoach.
- Seyedi-Sahebari et al. — The effects of Crocus sativus (saffron) on ADHD, J Atten Disord 2024 Systematic review of four clinical trials